TRIAL Holdings, Inc. (TYO:141A)
Japan
· Delayed Price · Currency is JPY 3,780.00
-20.00 (-0.53%)
Mar 10, 2026, 3:30 PM JST
TRIAL Holdings Revenue
TRIAL Holdings had revenue of 355.91B JPY in the quarter ending December 31, 2025, with 70.08% growth. This brings the company's revenue in the last twelve months to 1.08T, up 42.45% year-over-year. In the fiscal year ending June 30, 2025, TRIAL Holdings had annual revenue of 806.59B with 11.96% growth.
Revenue (ttm)
1,084.03B
Revenue Growth
+42.45%
P/S Ratio
0.43
Revenue / Employee
153.11M
Employees
7,080
Market Cap
466.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 806.59B | 86.15B | 11.96% |
| Jun 30, 2024 | 720.44B | 64.96B | 9.91% |
| Jun 30, 2023 | 655.48B | 55.64B | 9.28% |
| Jun 30, 2022 | 599.84B | 599.36B | 123,324.28% |
| Jun 30, 2021 | 486.00M | - | - |
| Mar 31, 2021 | Pro | Pro | Pro |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Japan Tobacco | 3,467.68B |
| Seven & i Holdings | 9,368.15B |
| Ajinomoto Co. | 1,543.69B |
| Pan Pacific International Holdings | 2,328.27B |
| Kewpie | 513.42B |
| Nisshin Seifun Group | 858.00B |
| Nichirei | 704.91B |
| Rohto Pharmaceutical | 335.80B |